AI assistant
Cravatex Ltd. — Interim / Quarterly Report 2020
Feb 12, 2020
63129_rns_2020-02-12_52d3b0bf-089d-4490-a6bb-21b015199700.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Registered Office �1atulya Centre 2nd Floor Seneoatr Bapal 1.iarg l uwer Parel W) Mumbai 400 011: CIN L93010MH 1951 PLC008546 T •91 22 6666 7474 F •91 22 2497 3210
r 3: =i m 0
E 1nfo@cravatex com W www cravatex com
==> picture [141 x 47] intentionally omitted <==
February 12 , 2020
BSE Limited
Department of Corporate Services (DCS-Listing) Phiroze Jeejeebhoy Towers Dalal Street Mumbai - 400 001
Company Code : 509472
Dear Sirs.
-
Sub: Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2019 Declaration of Interim Dividend for the Financial Year 2019-20
-
Ref: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
We wish to inform you that the Board of Directors of the Company at their meeting held today, which started at 05:15 p.m. and concluded at 6.05 p.m. have :
-
a) approved the Unaudited Financial Results (Standalone and Consolidated} of the Company for the quarter and nine months ended December 31, 2019. The Unaudited Financial Results (Standalone and Consolidated) together with the Limited Review Report of the Statutory Auditors on the aforesaid results are attached.
-
b) declared an Interim Dividend of Rs.2/· (20%) per Equity Share of Rs.10/- each for the Financial Year 2019-20.
Kindly take the above information on record.
==> picture [151 x 85] intentionally omitted <==
Company Secretary
Encl : a.a
Reqtstered Office Matutya Centre 2nd Floor Senapau Bapat Marg Lower Parel {W) Mumbai - 400 013 CIN L93010MH1951PLC008546
T •91 22 6666 7474 F •91 22 2497 3210
==> picture [159 x 50] intentionally omitted <==
E 1nfo@cravatex com W www cravatex com
(Rupees in Lacs)
(A) Statement of Standalone Unaudited Financial Results for the Quarter & Nine Months Ended on December 31, 2019
| Standalone | Standalone | |||||||
|---|---|---|---|---|---|---|---|---|
| SN | Pariculars | Quarerended (Unaudited) |
NineMonths ended (Unaudited) |
Yearended I Audited| |
||||
| Dec 31, | Sept 30, | Dec 31, | Dec31, | Dec 31, | March31, | |||
| 2019 | 2019 | 2018 | 2019 | 2018 | 2019 | |||
| I | Revenue from Operations | 35.78 | 145.42 | 62.55 | 184.24 | 81.08 | 103.95 | |
| II | Other Income | 259.13 | 248.93 | 243.50 | 619.98 | 591.21 | 707.70 | |
| Ill | TOTALINCOME (I +II) | 294.91 | 394.35 | 306.05 | 804.22 | 672.29 | 811.65 | |
| IV | EXPENSES | |||||||
| Purchase of Stock-in-Trade | 34.97 | 138.29 | 52.45 | 173.26 | 54.19 | 70.70 | ||
| Changein Inventories of Stock-in-Trade | 0.01 | 0.14 | 8.41 | 2.78 | 24.90 | 33.26 | ||
| Employee Benefits Expense | 29.13 | 29.76 | 24.24 | 85.51 | 72.36 | 99.97 | ||
| FinanceCosts | 24.65 | 18.09 | 23.16 | 61.58 | 77.00 | 101.59 | ||
| Depreciationand Amortisation Expense | 25.68 | 20.25 | 20.51 | 66.05 | 62.88 | 82.92 | ||
| Other Expenses | 62.27 | 21.38 | 31.73 | 104.87 | 10.57 | 128.00 | ||
| TOTAL EXPENSES (IV) | 176.71 | 227.91 | 160.SO | 494.05 | 391.90 | 516.44 | ||
| v | Profit/(Loss)before ExceptionalItemsand Tax(1)-(IV) | 118.20 | 166.44 | 145.54 | 310.17 | 280.39 | 295.21 | |
| VI | Exceptional Items | . | . | . | ||||
| VII | Profit/(Loss)before TaxExpenses{V - VI) | 118.20 | 166.44 | 145.54 | 310.17 | 280.39 | 295.21 | |
| VIII | TaxExpenses: | |||||||
| Current Tax | 23.01 | 15.93 | 14.80 | 44.53 | 48.80 | 69.50 | ||
| Deferred Tax | (4.00) | (13.18) | (25) | (19.61) | (8.68) | (111) | ||
| ShortI(Excess)provision | of the earlier period | (8.70) | 10.58 | 10.58 | ||||
| Total TaxExpense | 19.01 | 2.75 | 3.35 | 24.91 | 50.70 | 68.77 | ||
| IX | Proft/(Loss) for theperiod | (VII-VI) | 99.19 | 163.69 | 142.19 | 285.25 | 229.69 | 226.44 |
| x | Other ComprehensiveIncome fortheyear | . | (1.97) | |||||
| XI | TotalComprehensiveIncomefor theyear(IX+ X) | 99.19 | 163.69 | 142.19 | 285.25 | 229.69 | 224.47 | |
| XII | EarningsPer EquityShare(FaceValueRs.10each) | |||||||
| Basic | 3.84 | 6.33 | 5.50 | 11.04 | 8.89 | 8.69 | ||
| Diluted | 3.84 | 6.33 | 5.50 | 11.04 | 8.89 | 8.69 |
Notes:
-
1 The above financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on February 12, 2020.
-
2 This statement has been prepared in accordance with the Companies (Indian Accounting Standards) Rules 2015 (lnd AS) prescribed under Section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable.
-
3 The Company adopted Indian Accounting Standards (IND AS) from April 01, 2017, and accordingly, these financial results have been prepared in accordance with the recognition and measurement principles in IND AS 34 - Interim Financial Reporting, prescribed under section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and the other accounting principles generally accepted in India.
-
4 The statutory auditors have carried out a limited review of the standalone results for the quarter ended December 31, 2019.
-
5 The Company operates only in one primary business segment.
-
6 The Board of Directors at their meeting held on February 12, 2020 have declared an Interim Dividend of 20% ( at the rate of Rs. 2/- Per Equity share) for FY 2019-20.
==> picture [440 x 92] intentionally omitted <==
----- Start of picture text -----
7 Figures of the previous period's have been regrouped wherever necessary to conform to the current period class ns.
For Cravatex Limited
- -= �
0 I. ' �
1':' � ""? '� t;.,:.,.� '\ \ i/�}' ,,,,\ ·. ·, I - -I Ra- Jesh Batra .. - � ,a� o MUMBAI t:J m
Place : Mumbai ,.., "' �- r;��. . -e , "' ';j/ Chairman and Managing tor •
Date: February 12, 2020 �y DIN : 00020764
----- End of picture text -----
QPas��tes Chartered Accountants
vne Part.: Tel: +9122 2618 44 / 33 / 45 / 4646 105/106 Shyamkamal. [).6u11ding. Agarwal Mao<et. V,le Parle (East). Mumbai 400 057
Independent Auditor's Review Report on standalone unaudited quarterly and year to date financial results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended
To The Board of Directors Cravatex Limited
We have reviewed the accompanying statement of unaudited financial results of Cravatex Limited ('The Company') for the period ended 31[51 ] December 2019. This statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility is to issue a report on these financial statements based on our review.
We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement.
A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material miss ta temen t.
For GPS & Associates Chartered =r: tants Firm Reg . 344W '
Place: Mumbai Date: 12[1h ] February 2020
H.Y. Gurjar (Partner) M.No.: 032485
UDIN: U)0.3J..'1SSAAAAI\Cb<(;"t
Registered Office Malu1ya Centre 2nd Floor Senapan Bapat Marg Lower Pa rel (W) Murnba• 400 O 13 CIN L93010MH1951PLC008546 C008546 008546
r � CIN L93010MH1951PLC008546 C008546 008546 :::j T +91 22 6666 7474 F •91 22 2497 3210 I'll 0 E 1nfo@cravatex com W www cravatex com
__._R A E
| (Rupees m Locs) | (Rupees m Locs) | |||||||
|---|---|---|---|---|---|---|---|---|
| (B) PART-1:Statement of Unaudited Consolidated Unaudited FinancialResultfor theQuarter&NineMonths Ended on | December31, | 2019 | ||||||
| Quarter ended | Nine Months ended | Year ended | ||||||
| s,. | Particulars | December | September 30, | December 31, | December31, | December 31, | March31, | |
| No. | 312019 | 2019 | 2018 | 2019 | 2018 | 2019 | ||
| {Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | {Unaudited) | (Audited} | |||
| Income | ||||||||
| I | Revenuefrom Operations | 20,03.02 | 24,270.50 | 21,40.38 | 60,369.15 | 52,826.32 | 71,765.98 | |
| II | OtherIncome | 166.93 | 121.31 | 8647 | 414.02 | 286.88 | 415 76 | |
| I | TOTAL INCOME (I.II) | 20,259.95 | 24,391.81 | 21,495.85 | 60,783.17 | 53,113.19 | 72,181.74 | |
| IV | EXPENSES | |||||||
| Purchase of Stock-in-Trade | 12,41495 | 17,050.99 | 14,670.41 | 41,158.22 | 40,652.85 | SS,823 70 | ||
| Changein Inventories of Stock-in-Trade | 1,759.93 | (337.46) | 1,019.63 | 1,550.51 | (2,285.08) | (4,743.79) | ||
| Employee Benefts Expense | 1,651.32 | 1,713 82 | 1,107.96 | 4,608.79 | 3,086.87 | 5,212.98 | ||
| Finance Costs | 290.26 | 288 17 | 126.93 | 762.05 | 336.80 | 509.39 | ||
| Depreciation and Amort1sat1on Expense | 352.70 | 296.49 | 142.21 | 94115 | 412.70 | 573.28 | ||
| OtherExpenses | 3,589 03 | 4,282.61 | 3,519.54 | 10,674.67 | 8,775.44 | 13,117.79 | ||
| TOTAL EXPENSES (IV) | 20,058.19 | 23,294.61 | 20,586.68 | 59,695.39 | 50,979.58 | 70,493.35 | ||
| v | Proft/{loss) before Exceptional Items andTa"(1)-(IV) | 201.76 | 1,097.19 | 90.17 | 1,087.78 | 2,133.61 | 1,688.39 | |
| VI | txceptea!Items | |||||||
| VII | Proft/(loss) before Ta"Expenses (V-VI) | 201.76 | 1,097.19 | 909.17 | 1,087.78 | 2,133.61 | 1,688.39 | |
| VI | TaxExpenses: | |||||||
| Current Tax | 139 35 | 306.54 | 247.11 | 622.14 | 586.71 | 593.79 | ||
| DferredTax | (4 0) | {13.18) | (2.75) | {19 61) | (8.68) | 16 53 | ||
| ShortI(Excess)provision oftheearlier period | (8.70) | 10.58 | 1190 | |||||
| TotalTaxExpenses | 135.35 | 293.36 | 235.66 | 602.53 | 588.61 | 622.22 | ||
| IX | Proft/(Loss)for the period | (VII-VIII) | 66.41 | 803.83 | 673.51 | 485.25 | 1,545.0 | 1,06.17 |
| x | Other Comprehensive Incomeforthe year | (1.88) | (1.88) | (5.65) | (9.50) | |||
| XI | Total ComprehensiveIncomefor the year {IX. X) | 64.52 | 801.95 | 673.51 | 479.60 | 1,55.0 | 1,056.67 | |
| Netproftatributableto: | ||||||||
| Ownersof theHolding Company | 6642 | 803.84 | 673.52 | 485 30 | 1,545.02 | 1,066.20 | ||
| Non-controllingInterest | (O01) | (0.01) | (0.01) | {DOS) | (0.02) |
(0.03) | ||
| 66.41 | 803.83 | 673.51 | 485.25 | 1,545.0 | 1,0 .17 | |||
| OtherComprehensivelncome/(loss)atributable to: | ||||||||
| Owners of theHoldrngCompany | (1.88) | (188) | (S.65) | (9.50) | ||||
| Non-controllingInterest | (0.00) | (000) | (0.0) | (0.0) | ||||
| (1.88) | (l.88) | (5.65) | (9.50) | |||||
| TotalComprehensive lncome/(loss)atributable to: | ||||||||
| OwnersoftheHoldmg Company | 6.54 | 801.96 | 673.52 | 479.65 | 1,545.02 | 1,056.70 | ||
| Non-controlngInterest | (O01) | (0.01) | (0.01) | (0.05) | (002) |
(0.03) | ||
| 64.52 | (386.87) | 673.51 | 479.60 | 1,55.0 | 1,056.66 | |||
| XII | EarningsPerEquitShare (FaceValueRs. 10each) | |||||||
| easic | 2.57 | 31.11 | 26.0 | 18.78 | 59.79 | 41.26 | ||
| Diluted | 2.57 | 31.11 | 26.06 | 18.78 | 59.79 | 41.26 | ||
| Notes: |
l The above financial results have been reviewed by the Audit Committee and approved by the Board of Directors m their meeting held on February 12, 2020 The Statutory Auditors of Cravatex limited ('the Company') and its substdtanes {namely 'cravatex Brands limited' & BB (UK) ltd) [the Holdmg Company and its subsidiary together referred to as 'the Group'] have carried out limited review of the above results pursuant to Regulation 33 of the Securities and Exchange Board of India {listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and have issued an unmodified review opinion. The consohdated financial results for the quarter and nine months ended 31 December 2018 were not subjected to limited review by Statutory Auditors of the Company.
- 2 This statement has been prepared in accordance with the Companies (Indian Accountmg Standards) Rules 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable.
3 The figures for the quarter ended December 31, 2019 and December 31, 2018 are the balancing figures between the unaudited financial results for the nine months ended December 31, 2019 and December 31, 2018 and the pubhshed unaudited financial results for the six months ended on September 30, 2019 & Septembre 2018 respectively.
-
4 The statutory auditors have carried out a limited review of the consolidated results for the mne months ended December 31, 2019.
-
5 The financial statements of BB (UK) limited are prepared m accordance with United Kingdom Generaaly Accepted Accounting Principles (UK GAAP)
-
6 'The Board of Directors at their meeting held on February 12, 2020 have declared an Interim Dividend of 20% ( at the rate of Rs.2/- Per scuuv share) for FY 201920.
==> picture [184 x 77] intentionally omitted <==
----- Start of picture text -----
/,��� �p.T�
� .... ' � ( '
f.f � ,'}�-<'' 'i:) o ll?ull?e 41 Ji - I
��,�--·'.'.'{5' 1� ��
• 0
� �;����� ;jJ i)
----- End of picture text -----
7 Previous year I periods figures have been re-grouped/ re-classified wherever necessary.
Ql?s��tes Chartered Accountants
VIie Park: Te!· +91 22 2618 44 / 33 / 45 / 4646 105/106 Sllyamkamal. D-Bu1ld1ng. Agarwal Market. Vile Parle jEast), Mumbai 400 057
Independent Auditor's Review Report on consolidated unaudited quarterly and year to date financial results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended
To The Board of Directors Cravatex Limited
-
We have reviewed the accompanying Statement of Consolidated Unaudited Financial Results of Cravatex Limited (" the Parent") and its subsidiaries (the Parent and its subsidiaries together referred to as "the Group"), and its share of the net profit/(loss) after tax and total comprehensive income/loss of its associates and joint ventures for the quarter ended 31" December 2019 and year to date from 01[51 ] April, 2019 to 31'' December, 2019 (" the Statement"). The statement is being submitted by the Parent Company pursuant to the requirement of Regulation33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Attention is drawn to the fact that the consolidated figures for the corresponding quarter and nine months period ended 31" December 2018, as reported in these financial results have been approved by the Parent's Board of Directors, but have not been subjected to review.
-
This Statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.
-
We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
-
We also performed procedures in accordance with the circular no. CIR/CFD/CMDl/44/2019 dated March 29, 2019 issued by the SEBI under Regulation 33 (8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable.
==> picture [69 x 72] intentionally omitted <==
QJ?s��tes Chartered Accountants
-
The Statement includes the results of the following entities:
-
a. Cravatex Limited
-
b. Cravatex Brands Limited and
-
c. BB (UK) Limited.
-
Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review reports of the branch auditors and other auditors referred to in paragraph 7 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement.
-
We did not review the interim financial results of both subsidiaries included in the consolidated unaudited financial results, whose interim financial results reflect total assets of 35,151.54 Lakhs, total revenues of Rs.60,246.89 lakhs, total net profit after tax of Rs.467. 94 Lakhs and total comprehensive income of Rs.462.29 lakhs, for the nine months period ended 31[51 ] December 2019, as considered in the consolidated unaudited financial results, which have been reviewed by their respective independent auditors. The independent auditor's review reports on interim financial results of these entities have been furnished to us by the Management and our conclusion on the statement, in so far as it relates to the amounts and disclosures in respect of these subsidiaries is based solely on the report of such auditors and procedures performed by us as stated in paragraph 3 above.
-
Our conclusion on the Statement is not modified in respect of the above matter.
-
We were neither engaged to review, nor have we reviewed the comparative figures for the quarter and nine months period ended on 31st December, 2018 accordingly, we do not express any conclusion on the consolidated results in the Statement for the quarter and nine months period ended 31st December 2018. As set out in Note 1 to the Statement, these figures have been furnished by the Management.
-
Our conclusion on the Statement is not modified in respect of the above matter.
Place: Mumbai Date: }2th February 2020
==> picture [71 x 73] intentionally omitted <==
For GPS & Associates Chartered :i;,ountants .e1 N0(121344W . Gurjar (Partner) M.No.: 032485 UDIN: 2()02,'.l-'1£SAPIA!>.A)31 'b9